Acorda Therapeutics (ACOR)

Add to Watchlists Create an Alert
29.67 -0.86  -2.82% NASDAQ Sep 15, 4:59PM BATS Real time Currency in USD
View Full Chart
ACOR Price Chart
View All Events

ACOR Events

Date Type Description
07/31/2014 08:30 EDT Misc Acorda Therapeutics, Inc. Q2 2014 Earnings Conference Call
07/31/2014 Earnings Acorda Therapeutics, Inc. Q2 2014 Earnings Results
06/05/2014 Misc Annual General Meeting for Acorda Therapeutics Inc
05/06/2014 08:30 EDT Misc Acorda Therapeutics, Inc. Q1 2014 Earnings Conference Call
05/06/2014 Earnings Acorda Therapeutics, Inc. Q1 2014 Earnings Results
02/13/2014 08:30 EST Misc Acorda Therapeutics, Inc. Q4 2013 Earnings Conference Call
02/13/2014 Earnings Acorda Therapeutics, Inc. Q4 2013 Earnings Results
10/31/2013 08:30 EDT Misc Acorda Therapeutics, Inc. Q3 2013 Earnings Conference Call
10/31/2013 Earnings Acorda Therapeutics, Inc. Q3 2013 Earnings Release
View All Performance Charts

ACOR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Acorda Therapeutics is down 20.13% over the last year vs S&P 500 Total Return up 20.32%, Biogen Idec up 36.73%, and Actavis up 72.18%.

Get Quote for

PDF Report for ACOR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ACOR Pro Report PDF
Advertisement

Portfolio Strategies Featuring ACOR

Did Acorda Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ACOR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.acorda.com
  • IR Website: http://ir.acorda.com/investors/default.aspx
  • HQ Country: United States
  • HQ State/Province: New York
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Acorda Therapeutics, Inc. is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of multiple sclerosis, spinal cord injury & other disorders of the central nervous system.

ACOR Excel Add-In Codes

  • Name: =YCI("ACOR","name")
  • Description: =YCI("ACOR","description")
  • Sector: =YCI("ACOR","sector")
  • Industry: =YCI("ACOR","industry")
  • Est. Current Fiscal Year End: =YCI("ACOR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.